Comparative Effects of Ciprofol and Propofol on Pain Intensity on the First Day After Surgery: a Retrospective, Propensity Score Matched, Cohort Study
Sponsor
Guangdong Second Provincial General Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT06020469
Collaborator
(none)
6,500
1
2
3243.3
Study Details
Study Description
Brief Summary
Data intelligence platform was widely used to facilitate the process of clinical research. However, a platform that integrates natural language processing (NLP) and machine learning (ML) algorithms has not been reported in perioperative medical management.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
6500 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Comparative Effects of Ciprofol and Propofol on Pain Intensity of the Patients Without PCA on the First Day After Surgery: a Retrospective, Propensity Score Matched, Cohort Study
Anticipated Study Start Date
:
Oct 1, 2023
Anticipated Primary Completion Date
:
Oct 1, 2023
Anticipated Study Completion Date
:
Dec 1, 2023
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Numeric Rating Scale (NRS) score after surgery <4
|
|
Numeric Rating Scale (NRS) score after surgery ≥ 4
|
Outcome Measures
Primary Outcome Measures
- Area under the curve [October 2022 to October 2023]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Patients were included if they were above 18 years old, undergoing non-local anesthesia surgery.
Exclusion Criteria:
-
The basic information such gender, age, height, weight, and body mass index (BMI) were missing.
-
Patients undergoing day surgery, with a history of multiple operations, or entering ICU after surgery, and losing the NRS score during movement at 24h after surgery.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Guangdong Second Provincial General Hospital | Guangzhou | Guangdong | China |
Sponsors and Collaborators
- Guangdong Second Provincial General Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Hui Zhang,
associate chief physician,
Guangdong Second Provincial General Hospital
ClinicalTrials.gov Identifier:
NCT06020469
Other Study ID Numbers:
- GD2HMZK
First Posted:
Aug 31, 2023
Last Update Posted:
Aug 31, 2023
Last Verified:
Aug 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hui Zhang,
associate chief physician,
Guangdong Second Provincial General Hospital
Additional relevant MeSH terms: